NASDAQ (USD): Y-mAbs Therapeutics, Inc. (YMAB)
Last Price
11.72
Today's Change
-1.455 (11.03%)
Day's Change
11.50 - 12.96
Trading Volume
313,609
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Stock Price
238
1000
110
900
600
12
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
Trump in Phone Call Advised Putin Not to Escalate in Ukraine — Washington Post
2
US Ordered TSMC to Halt Shipments of Chips for AI to China — Reuters
3
Dogecoin Outperforms Bitcoin as Trump Spurs Crypto Speculation
4
Hedge Funds Shorting Tesla Just Lost More Than US$5 Bil
5
Trump Seeks Fast Appointments; Elon Musk Makes Endorsement for Senate Leadership
#
Stock
Score
MSTR
MicroStrategy Incorporated
AGN
833
BABA
Alibaba Group Holding Limited
666
KXIN
Kaixin Auto Holdings
BITF
Bitfarms Ltd.
6
AAPL
Apple Inc.
500
7
PLTR
Palantir Technologies Inc.
466
8
CHMT
333
9
UEIC
Universal Electronics Inc.
10
NOC
Northrop Grumman Corporation
Last
Change
Volume
ELAB
0.026
+0.001
1,710,756,250
XTIA
0.052
-0.005
351,738,722
MTEM
0.627
+0.305
323,408,908
SVMH
0.027
+0.003
240,894,362
QUBT
4.31
+1.65
222,586,957
MVST
0.77
-0.025
169,906,978
UAVS
3.35
+1.74
163,944,227
NVDA
146.01
-0.26
162,245,979
LMDX
0.016
-0.018
120,553,903
BRK-A
703,153.28
+903.25
1,358
NVR
9,168.00
+62.33
12,290
DDS
436.82
+48.31
185,801
MKL
1,701.88
+46.52
49,690
BH-A
1,050.00
+33.00
972
ASML
694.42
+21.01
3,401,240
BLK
1,046.20
+15.22
575,215
FSLR
194.21
+12.08
4,439,418
SPOT
478.30
+10.93
4,286,247
CYBR
302.21
+10.60
686,473
MELI
1,774.05
-343.25
2,940,447
1,309.00
-138.99
2,237,917
1,395.13
-102.30
318,280
NOW
643.29
-87.83
5,025,012
TDG
1,278.16
-84.84
502,175
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
1,873.40
-57.545
424,742
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....